Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Exparel® (bupivacaine) – New indication
April 6, 2018 - Pacira announced the FDA approval of Exparel (bupivacaine liposome injectable suspension) as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.
